Hiebert C K, Kopp W C, Richerson H B, Barfknecht C F
Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City 52242.
J Med Chem. 1988 Oct;31(10):2022-4. doi: 10.1021/jm00118a029.
Muramyl dipeptide (MDP) analogues were prepared and utilized in the synthesis of new fluorescently labeled MDP derivatives for use as biologic probes. Thus, N alpha-(N-acetylmuramyl)-L-lysyl-D-isoglutamine (Lys-MDP, 4) and N alpha-(N-acetylmuramyl)-L-alanyl-D-isoglutaminyl)-L-lysine [MTP, 5] were synthesized and then reacted with 2-(fluoresceinylamino)-4,6-dichloro-s-triazine (DTAF, 2) to yield the fluorescent adducts, DTAF-Lys-MDP (6) and DTAF-MTP (7). The adjuvant activity of the fluorescent MDP derivatives was determined by the ability of the compounds to promote delayed skin test responses in guinea pigs immunized with ovalbumin (OA) and by evaluating the anti-OA activity of these guinea pigs.
制备了胞壁酰二肽(MDP)类似物,并将其用于合成新型荧光标记的MDP衍生物,用作生物探针。因此,合成了Nα-(N-乙酰胞壁酰)-L-赖氨酰-D-异谷氨酰胺(Lys-MDP,4)和Nα-(N-乙酰胞壁酰)-L-丙氨酰-D-异谷氨酰胺基)-L-赖氨酸[MTP,5],然后使其与2-(荧光素基氨基)-4,6-二氯-s-三嗪(DTAF,2)反应,生成荧光加合物DTAF-Lys-MDP(6)和DTAF-MTP(7)。通过化合物促进用卵清蛋白(OA)免疫的豚鼠迟发性皮肤试验反应的能力以及评估这些豚鼠的抗OA活性,来确定荧光MDP衍生物的佐剂活性。